H-Ras

H-Ras (HRAS) is a small GTPase that functions as a GDP/GTP-regulated molecular switch linking activated cell-surface receptors to intracellular signaling networks that control cell proliferation, differentiation, survival, and migration^[4][5]. Mechanistically, H-Ras cycles between inactive GDP-bound and active GTP-bound states and transmits signals through major effector pathways, including the RAF-MEK-ERK and PI3K-AKT cascades, thereby coordinating growth factor-dependent cellular responses^[6][1]. In disease contexts, activating HRAS mutations promote persistent downstream signaling and contribute to multiple human malignancies, with notable involvement in bladder, thyroid, head and neck, and oral squamous cell carcinomas^[7][2]. Compared with related Ras isoforms, H-Ras, K-Ras, and N-Ras share highly conserved G-domains but differ substantially within their C-terminal hypervariable regions, which determine membrane trafficking, subcellular localization, and isoform-specific signaling outputs^[4][8]. H-Ras is further distinguished by its dynamic palmitoylation-dependent trafficking between the plasma membrane and endomembrane compartments, enabling spatially restricted signal transduction and context-dependent biological effects^[8][3]. These isoform-specific properties make H-Ras an important experimental model for dissecting Ras signaling compartmentalization and oncogenic network regulation^[4][8]. For experimental and translational applications, H-Ras remains a particularly tractable therapeutic target because its membrane localization depends on farnesylation, and pharmacological farnesyltransferase inhibitors such as tipifarnib can suppress H-Ras-dependent signaling in selected tumor models^[2][9].